Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

HIV-derived protein gp120 suppresses P3 potential in rats: potential implications in HIV-associated dementia.

Galicia O, Sánchez-Alavez M, Díaz-Ruíz O, Sánchez Narváez F, Elder JH, Navarro L, Prospéro-García O.

Neuroreport. 2000 Apr 27;11(6):1351-5.

PMID:
10817620
2.

Acoustically evoked event-related potentials in HIV-associated dementia.

Arendt G, Hefter H, Jablonowski H.

Electroencephalogr Clin Neurophysiol. 1993 Mar;86(3):152-60.

PMID:
7680990
3.

[Cognitive evoked potentials and HIV infection].

Gil R, Breux JP, Neau JP, Becq-Giraudon B.

Neurophysiol Clin. 1992 Nov;22(5):385-91. Review. French.

PMID:
1484519
4.

HIV- and FIV-derived gp120 alter spatial memory, LTP, and sleep in rats.

Sánchez-Alavez M, Criado J, Gómez-Chavarín M, Jiménez-Anguiano A, Navarro L, Díaz-Ruiz O, Galicia O, Sánchez-Narváez F, Murillo-Rodríguez E, Henriksen SJ, Elder JH, Prospéro-García O.

Neurobiol Dis. 2000 Aug;7(4):384-94.

PMID:
10964609
5.

Event-related potentials of the rat during active and passive auditory oddball paradigms.

Shinba T.

Electroencephalogr Clin Neurophysiol. 1997 Sep;104(5):447-52.

PMID:
9344081
6.

Latency variability and temporal interrelationships of the auditory event-related potentials (N1, P2, N2, and P3) in normal subjects.

Michalewski HJ, Prasher DK, Starr A.

Electroencephalogr Clin Neurophysiol. 1986 Jan;65(1):59-71.

7.

Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120.

Barak O, Goshen I, Ben-Hur T, Weidenfeld J, Taylor AN, Yirmiya R.

Brain Res. 2002 Apr 19;933(2):98-108.

PMID:
11931854
8.

Nicotine prevents HIVgp120-caused electrophysiological and motor disturbances in rats.

González-Lira B, Rueda-Orozco PE, Galicia O, Montes-Rodríguez CJ, Guzmán K, Guevara-Martínez M, Elder JH, Prospéro-García O.

Neurosci Lett. 2006 Feb 13;394(2):136-9. Epub 2005 Nov 2.

PMID:
16269213
9.
10.

[HIV glycoprotein 120: possible etiological agent of AIDS-associated dementia].

Galicia O, Sánchez-Alavez M, Méndez Díaz M, Navarro L, Prospero-García O.

Rev Invest Clin. 2002 Sep-Oct;54(5):437-52. Review. Spanish.

PMID:
12587419
12.

Microglial activation and neurological symptoms in the SIV model of NeuroAIDS: association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changes.

Berman NE, Marcario JK, Yong C, Raghavan R, Raymond LA, Joag SV, Narayan O, Cheney PD.

Neurobiol Dis. 1999 Dec;6(6):486-98.

PMID:
10600404
13.

[Long latency auditory evoked potentials in adults with HIV/Aids].

Silva AC, Pinto FR, Matas CG.

Pro Fono. 2007 Oct-Dec;19(4):352-6. Portuguese.

14.
15.

HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates.

Hill JM, Mervis RF, Avidor R, Moody TW, Brenneman DE.

Brain Res. 1993 Feb 19;603(2):222-33.

PMID:
8461978
16.

gp120 as an etiologic agent for NeuroAIDS: neurotoxicity and model systems.

Brenneman DE, McCune SK, Mervis RF, Hill JM.

Adv Neuroimmunol. 1994;4(3):157-65. Review.

PMID:
7874383
17.
18.

Effects of stimulus repetitions on the event-related potential of humans and rats.

Sambeth A, Maes JH, Quian Quiroga R, Coenen AM.

Int J Psychophysiol. 2004 Aug;53(3):197-205.

PMID:
15246673
19.

ERP development in the rat in the course of learning two-tone discrimination task.

Takeuchi S, Jodo E, Suzuki Y, Matsuki T, Hoshino KY, Niwa SI, Kayama Y.

Neuroreport. 2000 Feb 7;11(2):333-6.

PMID:
10674481
20.

In vivo trapping of nitric oxide in the brain of neonatal rats treated with the HIV-1 envelope protein gp 120: protective effects of alpha-phenyl-tert-butylnitrone.

Tabatabaie T, Stewart C, Pye Q, Kotake Y, Floyd RA.

Biochem Biophys Res Commun. 1996 Apr 16;221(2):386-90.

PMID:
8619865

Supplemental Content

Support Center